33 records found.
Oct 15, 2019
Bausch Health's Ortho Dermatologics Business To Present Data At The Fall Clinical Dermatology Conference
Oct 10, 2019
Foamix to Present Data on its Topical Product Candidates for Acne, Rosacea at 39th Annual Fall Clinical Dermatology Conference
Oct 04, 2019
Galderma Receives FDA Approval for AKLIEF® (trifarotene) Cream, 0.005%, the First New Retinoid Molecule for the Treatment of Acne in Over 20 Years
Oct 04, 2019
Klox Technologies Inc. Announces Completion of the Acquisition of FB Dermatology
Oct 01, 2019
Monitoring Moles: Stay Alert to Stay Safe from Deadly Skin Cancer
Aug 06, 2019
Exceed Microneedling device first to receive FDA clearance for the treatment of wrinkles and acne scarring.
Aug 05, 2019
Foamix Submits New Drug Application to U.S. FDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea
Jun 20, 2019
American Acne And Rosacea Society (AARS) Uncovers Real Impact Of Acne On Young Professionals During Acne Awareness Month
Jun 17, 2019
Almirall Partners With AARS To Raise Awareness About The Burden Of Disease And Importance Of Education For Dermatology Professionals For National Acne Awareness Month
Apr 26, 2019
Seeing Spots: Understanding the Skin Cancer Risks of Moles
Mar 29, 2019
Micreos Raises EUR30 Million for Endolysin Technology Set to Replace Antibiotics
Feb 14, 2019
Leading Dermatologists Develop Consensus Guidelines for the Use of Superficial Radiation Therapy to Treat Non-Melanoma Skin Cancers and Keloids
Nov 19, 2018
Surging Demand for Acne Treatment to Push Dermatological Product Sales to Over US$ 13 Billion in 2018, Finds Fact.MR
Oct 15, 2018
Bausch Health's Ortho Dermatologics Business To Present New Scientific Data During The Fall Clinical Dermatology Conference
Oct 11, 2018
BioPharmX Initiates Phase 2b Trial of BPX-04 for Rosacea
Oct 11, 2018
Sebacia EU Real-World Results Demonstrate an Average 79% Improvement in Acne at 6 Months
Sep 14, 2018
Experts Call for Improved Identification of 'High Burden' Rosacea Patients in Everyday Practice
Aug 29, 2018
FDA Accepts Resubmission Of New Drug Application For Duobrii(TM)1 (Halobetasol Propionate And Tazarotene) Lotion
Aug 15, 2018
Ortho Dermatologics Resubmits U.S. New Drug Application For DUOBRII(TM) (halobetasol propionate and tazarotene) Lotion
Aug 08, 2018
Restylane Lyft for Hand Rejuvenation Now Available at Maryland Dermatology Laser Skin & Vein Institute

Pages